160 related articles for article (PubMed ID: 8704706)
1. Reconstitution with Philadelphia chromosome-negative recipient haematopoiesis early after allogeneic BMT for CML.
Sill H; Rule SA; Joske DJ; Chase A; Lin F; Goldman JM; Cross NC
Bone Marrow Transplant; 1996 Mar; 17(3):453-5. PubMed ID: 8704706
[TBL] [Abstract][Full Text] [Related]
2. Autologous reconstitution with BCR-ABL-negative haematopoiesis after T cell-depleted allogeneic BMT for CML.
Serrano J; Román J; Castillejo JA; Sánchez J; Navarro JA; Martín C; Herrera C; Torres A
Bone Marrow Transplant; 1998 Sep; 22(6):599-601. PubMed ID: 9758352
[TBL] [Abstract][Full Text] [Related]
3. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.
Gardiner N; Lawler M; O'Riordan J; DeArce M; Humphries P; McCann SR
Bone Marrow Transplant; 1997 Aug; 20(3):235-41. PubMed ID: 9257892
[TBL] [Abstract][Full Text] [Related]
4. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
[TBL] [Abstract][Full Text] [Related]
5. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
[TBL] [Abstract][Full Text] [Related]
7. Serial cytogenetic studies in allografted patients with chronic myeloid leukemia.
Bilhou-Nabera C; Bernard P; Marit G; Viard F; Gharbi MJ; Wen Z; Lacombe F; Broustet A; Reiffers J
Bone Marrow Transplant; 1992 Apr; 9(4):263-8. PubMed ID: 1600414
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
[TBL] [Abstract][Full Text] [Related]
9. Relapse in chronic myeloid leukemia after bone marrow transplantation: biomathematical modeling as a new approach to understanding pathogenesis.
Vincent PC; Rutzen-Loesevitz L; Tibken B; Heinze B; Hofer EP; Fliedner TM
Stem Cells; 1999; 17(1):9-17. PubMed ID: 10215403
[TBL] [Abstract][Full Text] [Related]
10. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
Mackinnon S; Barnett L; Heller G
Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
[TBL] [Abstract][Full Text] [Related]
11. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia.
Konstantinidou P; Szydlo RM; Chase A; Goldman JM
Bone Marrow Transplant; 2000 Jan; 25(2):143-6. PubMed ID: 10673671
[TBL] [Abstract][Full Text] [Related]
13. Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients.
Zaccaria A; Rosti G; Sessarego M; Frassoni F; Marmont A; Galimberti M; Baronciani D; Filippetti A; Di Bartolomeo P; Di Girolamo G
Bone Marrow Transplant; 1988 Sep; 3(5):413-23. PubMed ID: 3056550
[TBL] [Abstract][Full Text] [Related]
14. Non-leukemic autologous reconstitution after allogeneic bone marrow transplantation for Ph-positive chronic myelogenous leukemia: extended remission preceding eventual relapse.
Brunstein CG; Hirsch BA; Miller JS; McGlennen RC; Verfaillie CM; McGlave PB; Weisdorf DJ
Bone Marrow Transplant; 2000 Dec; 26(11):1173-7. PubMed ID: 11149727
[TBL] [Abstract][Full Text] [Related]
15. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation.
Wakui M; Okamoto S; Ishida A; Tanosaki R; Mori T; Kawai Y; Ohshima S; Ikeda Y
Bone Marrow Transplant; 1996 Oct; 18(4):801-4. PubMed ID: 8899199
[TBL] [Abstract][Full Text] [Related]
16. Achievement of complete cytogenetic remission after two very low-dose donor leucocyte infusions in a patient with extensive cGVHD relapsing in accelerated phase post allogeneic BMT for CML.
Rahman SL; Mahendra P; Nacheva E; Sinclair P; Arno J; Marcus RE
Bone Marrow Transplant; 1998 May; 21(9):955-6. PubMed ID: 9613792
[TBL] [Abstract][Full Text] [Related]
17. Successful second unrelated donor BMT in a child with juvenile chronic myeloid leukaemia: documentation of chimaerism using the polymerase chain reaction.
Pamphilon DH; Cornish JM; Goodman S; Ball L; Lawler M; McCann S; Humphries P; Oakhill A
Bone Marrow Transplant; 1993 Jan; 11(1):81-4. PubMed ID: 8431716
[TBL] [Abstract][Full Text] [Related]
18. Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
Hambach L; Eder M; Dammann E; Battmer K; Stucki A; Heil G; Ganser A; Hertenstein B
Bone Marrow Transplant; 2001 Oct; 28(7):705-7. PubMed ID: 11704795
[TBL] [Abstract][Full Text] [Related]
19. Relapse after allogeneic BMT for chronic myeloid leukemia (CML) may be sustained by a small number of leukemic 'stem cells': a hypothesis.
Frassoni F; Podestà M; Piaggio G; Pitto A; Figari O; Soracco M; Lint M; Fugazza G; Sessarego M; Bacigalupo A
Bone Marrow Transplant; 1999 Sep; 24(6):689-91. PubMed ID: 10490738
[TBL] [Abstract][Full Text] [Related]
20. Prolonged remission and autologous recovery in two patients with chronic myelogenous leukemia after graft failure of allogeneic bone marrow transplantation.
Fouillard L; Deconinck E; Tiberghien P; Deschaseaux ML; Solary E; Mugneret F; Brion A; Herve P; Cahn JY
Bone Marrow Transplant; 1998 May; 21(9):943-6. PubMed ID: 9613789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
